Analyst firms · J.P. Morgan · MRSN

J.P. Morgan MRSN price target and rating history

Mersana Therapeutics Inc. (MRSN) · Health Care

J.P. Morgan rates Mersana Therapeutics Inc. (MRSN) Neutral with a $5 price target, as of its latest action on Mar 19, 2024. It has published 4 rating actions on MRSN since March 2023, including 2 upgrades and 2 downgrades.

Current rating
Neutral
Price target
$5
Median target, all firms
Too few
Actions on MRSN
4

J.P. Morgan price target on MRSN

$10$7.50$5202420252026
J.P. Morgan price target on MRSN, each point a stated target, March 2023 to March 2024.

Every J.P. Morgan rating on MRSN

Questions about J.P. Morgan and MRSN

What is J.P. Morgan's price target for MRSN?
J.P. Morgan's latest stated price target for Mersana Therapeutics Inc. (MRSN) is $5, from its action on Mar 19, 2024.
What is J.P. Morgan's rating on MRSN?
J.P. Morgan rates MRSN Neutral, a neutral rating, as of Mar 19, 2024.
When did J.P. Morgan last change its view on MRSN?
On Mar 19, 2024, J.P. Morgan upgrades to Neutral from Underweight, price target $5.

More MRSN rating histories

All J.P. Morgan ratingsMRSN news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.